Stocks Above the 200-Day Moving Average — Financial View · Services-Commercial Physical & Biological Research
9 stocks match the Stocks Above the 200-Day Moving Average screen. Stocks trading above their 200-day moving average — a long-term uptrend filter, largest first. Financial columns. Filtered to Services-Commercial Physical & Biological Research. Data as of close · Checked
| IQV | IQVIA | $43.7B | — | 4.6% | 20.9% | 6.5% | 0.83 | 2.23 | — | 12.8% | 8.1% | 264.87 | +0.43% | 156K |
| INCY | Incyte | $24.0B | — | 5.5% | 7.1% | 1.6% | 3.84 | 3.38 | 92.7% | 10.4% | 6.7% | 117.98 | -4.02% | 76K |
| MEDP | Medpace Holdings, Inc. | $17.8B | — | 22.5% | 88.5% | 88.5% | 0.83 | 0.00 | — | 21.4% | 18.2% | 635.08 | -3.25% | 19K |
| CRL | Charles River Laboratories | $15.0B | — | 0.5% | 1.2% | 0.8% | 1.41 | 0.50 | — | 4.0% | 1.0% | 312.93 | -4.10% | 150K |
| ABSI | Absci Corp | $1.6B | — | -45.0% | -49.2% | -48.4% | 10.63 | 0.02 | — | — | — | 9.34 | -11.10% | 322K |
| OABI | OmniAb, Inc. | $703M | — | -14.9% | -17.4% | -17.4% | 4.21 | 0.17 | — | — | — | 4.82 | -6.86% | 87K |
| NRC | Nrc Health | $541M | 2.2% | 8.3% | — | — | 0.64 | — | — | 11.1% | 8.4% | 25.47 | -5.75% | 9K |
| MXCT | MAXCYTE, INC. | $134M | — | -19.3% | -22.4% | -22.4% | 12.26 | 0.16 | — | — | — | 1.30 | -5.80% | 61K |
| ICLR | Icon Plc | — | — | 2.8% | 4.9% | 3.6% | 1.32 | 0.37 | — | 8.7% | 5.4% | 201.81 | -0.60% | 127K |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials: Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it. A company reporting in another currency is shown in ≈ USD: its figures convert at the Federal Reserve H.10 rate of its price date (FRED), and without a rate its multiples are blank. This product uses the FRED® API but is not endorsed or certified by the Federal Reserve Bank of St. Louis. Informational only — not financial advice.